The Promise of Psychedelics for Mental Health and Addiction [Video]

In this episode of Atria’s Vanguard Symposia, renowned psychopharmacologist Dr. David Nutt explores the potential of psychedelics for mental health treatment, addressing critical challenges like depression, PTSD, and addiction. He dispels stigmas surrounding psychedelics, highlighting their emerging scientific validation as therapeutic agents and guiding listeners through his research on an array of promising drugs. Dr. Nutt explains how these substances disrupt maladaptive neural networks and foster new connections, promoting cognitive flexibility and symptom relief. He examines the scientific, ethical, and regulatory aspects of psychedelic-assisted therapy, offering a glimpse into a future of mental health care that targets suffering at its roots.

Atria’s Vanguard Symposia is a lecture series where some of the world’s most compelling researchers translate leading-edge science into medicine. In each episode, top experts share breakthrough science about preventive health care, dive deep into headline-grabbing topics, and take you beyond the buzzwords to explain the latest in longevity science. Our show will arm you with practical information and the tools of discernment to cut through the hype and understand what matters most.

Atria Health and Research Institute aims to accelerate a global shift from reactive sick care to proactive, preventive health care. We work at the forefront of science and technology and we believe a collaborative approach to modern medicine can extend healthy life for all.